June 7, 2018 07:35 AM EDT
Financing
China

Man­u­fac­tur­ing ex­perts at Hangzhou Just Bio­ther­a­peu­tics bank $35M for stealthy R&D in Chi­na and the US

Amber Tong

Hill­house Cap­i­tal has joined sev­er­al promi­nent in­vest­ment firms in back­ing an an­ti­body and re­com­bi­nant pro­tein com­pa­ny’s en­try to the clin­ic with $35 mil­lion.

Be­tween sites …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Up­dat­ed: Am­gen obe­si­ty shot shows 20% weight loss, but dos­ing ques­tions hang over read­out

Up­dat­ed: Roche buys out CAR-T part­ner Po­sei­da for $1B up­front

Alec­tor says Alzheimer's pro­gram tar­get­ing mi­croglia fails Phase 2, stock dives

Roche’s TIG­IT drug miss­es last shot at sur­vival end­point win in Phase 3 lung can­cer tri­al

How did Trump’s FDA pick land? Biotech stocks are up, and ex­ec­u­tives are (most­ly) re­lieved

Trump team asked Warp Speed leader to head NIH, may seek more tra­di­tion­al pick for role

A service from the Financial Times